Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01680744 · ClinicalTrials.gov registry record · NA
The Effect of Therapeutic Hypothermia on Deceased Donor Renal Graft Outcomes - a Randomized Controlled Trial From the Region 5 Donor Management Goals Workgroup
A NA study of Renal Function and Deceased Organ Donor, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 370
- Enrollment target
- 1
- Study location
NCT01680744 is a NA study of Renal Function and Deceased Organ Donor that has completed, run by University of California, San Francisco. The registered enrollment target is 370 participants, above the 172-participant average among 3 other Renal Function trials with a reported enrollment target (115% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01680744, a NA study of Renal Function and Deceased Organ Donor, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 370 participants
- Enrollment target
- 1
- Study location
Study Summary
To protect kidney function during the transplantation process by inducing mild hypothermia in the deceased organ donor before organs are recovered
Conditions Studied
Interventions
- OTHER Hypothermia
Study Locations (1)
California
- University of California San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 370 participants |
| Start Date | 2012-05 |
| Est. Completion | 2014-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01680744
The ClinicalTrials.gov registry entry for NCT01680744 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 370 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 172-participant average among 3 other Renal Function trials with a reported enrollment target (115% higher). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Renal Function appearing as the primary indexed condition, and to 1 intervention - of which Hypothermia is the first listed.
NCT01680744 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01680744 about?
NCT01680744 is a clinical study titled "The Effect of Therapeutic Hypothermia on Deceased Donor Renal Graft Outcomes - a Randomized Controlled Trial From the Region 5 Donor Management Goals Workgroup". To protect kidney function during the transplantation process by inducing mild hypothermia in the deceased organ donor before organs are recovered
What is the current status of trial NCT01680744?
This trial is currently completed. It is a NA study. The enrollment target is 370 participants. The study started on 2012-05. Estimated completion is 2014-11.
What conditions does trial NCT01680744 study?
This clinical trial studies the following conditions: Renal Function, Deceased Organ Donor, Mild Hypothermia.
What interventions are being tested in trial NCT01680744?
The interventions under investigation include: Hypothermia (OTHER).
Who is sponsoring clinical trial NCT01680744?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01680744 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Renal Function
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Influence of Mitochondrial-Derived Reactive Oxygen Species on Racial Disparities in Neurovascular Function
RECRUITING · NA
-
A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population
RECRUITING
-
Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients.
COMPLETED · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.